Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases
Data up to Jan 2025
Total Citations Per Year
Abstract
References (44)
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
2004 • 10,779 citations
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
1989 • 4,988 citations
Vascular endothelial growth factor (VEGF) and its receptors
1999 • 3,498 citations
CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
1997 • 2,470 citations
High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
1993 • 1,961 citations
Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.
1994 • 1,661 citations
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
2001 • 1,640 citations
Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
1996 • 1,355 citations
Regulation, substrates and functions of src
1996 • 1,173 citations
Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
1998 • 1,077 citations
Selective Requirement for Src Kinases during VEGF-Induced Angiogenesis and Vascular Permeability
1999 • 802 citations
Src family kinases in tumor progression and metastasis.
2003 • 787 citations
Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.
1999 • 543 citations
Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration
2000 • 435 citations
Congenital Hereditary Lymphedema Caused by a Mutation That Inactivates VEGFR3 Tyrosine Kinase
2000 • 415 citations
Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer.
1993 • 396 citations
Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis.
2001 • 345 citations
Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor–positive human tumors
2001 • 343 citations
Vessel Counts and Expression of Vascular Endothelial Growth Factor as Prognostic Factors in Node-Negative Colon Cancer
1997 • 333 citations
Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells
2005 • 333 citations
Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias
2001 • 275 citations
pp60c-src activation in human colon carcinoma.
1989 • 267 citations
Activation of Src kinase in primary colorectal carcinoma
2002 • 249 citations
Identification of Src-Specific Phosphorylation Site on Focal Adhesion Kinase: Dissection of the Role of Src SH2 and Catalytic Functions and Their Consequences for Tumor Cell Behavior
2005 • 213 citations
Src activation regulates anoikis in human colon tumor cell lines
2002 • 210 citations
The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer.
2001 • 210 citations
Down-regulation of Vascular Endothelial Growth Factor in a Human Colon Carcinoma Cell Line Transfected with an Antisense Expression Vector Specific for c-src
1998 • 204 citations
Expression of vascular endothelial growth factor receptors in human prostate cancer
1999 • 202 citations
Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML
2004 • 196 citations
Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF‐R1‐Flt1 and VEGF‐R2‐Flk1/KDR) in non‐small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival
1999 • 177 citations
Human Melanoma Cells Secrete and Respond to Placenta Growth Factor and Vascular Endothelial Growth Factor
2000 • 171 citations
Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo
2004 • 124 citations
c-Yes tyrosine kinase activity in human colon carcinoma.
1993 • 108 citations
Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells.
2002 • 97 citations
Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma
2000 • 87 citations
AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes
2005 • 79 citations
The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse model
2005 • 70 citations
In vitro and in vivo activity of ATP-based kinase inhibitors AP23464 and AP23848 against activation-loop mutants of Kit
2005 • 61 citations
FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells
1998 • 59 citations
c-Src Mediates Mitogenic Signals and Associates with Cytoskeletal Proteins upon Vascular Endothelial Growth Factor Stimulation in Kaposi’s Sarcoma Cells
2000 • 43 citations
Comparative Structure‐Function Analysis of VEGFR‐1 and VEGFR‐2
2003 • 39 citations
Vascular endothelial growth factor and cellular chemotaxis: a possible autocrine pathway in adult T-cell leukemia cell invasion.
2001 • 35 citations
The tubulogenic activity associated with an activated form of Flt-1 kinase is dependent on focal adhesion kinase
2001 • 17 citations
Antitumor effects of synthetic VEGF-receptor binding antagonist, VGA1155.
2005 • 8 citations